Lisinopril and Hydrochlorothiazide

Product NDC
68788-8075
11-digit product format
687888075
Labeler code
68788
Product ID
68788-8075_eee3fd4f-203f-4883-aa69-143bc19ea4d6
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lisinopril and Hydrochlorothiazide Tablets
Dosage form
TABLET
Route
ORAL
Labeler
Preferred Pharmaceuticals Inc.
Application
ANDA204058
Marketing category
ANDA
Marketing start
2021-08-27
Marketing end
0000-00-00
Substance
HYDROCHLOROTHIAZIDE; LISINOPRIL
Active strength
13 mg/1; mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68788-8075LISINOPRIL AND HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS) TABLET [PREFERRED PHARMACEUTICALS INC.]4Legacy NDC20240621_0dec7764-9f8e-41d9-99b9-8f7155506c3b.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
68788-8075-168788807501100 TABLET in 1 BOTTLE (68788-8075-1) 100 tablet2021-08-270000-00-00NoNoCurrent
68788-8075-36878880750330 TABLET in 1 BOTTLE (68788-8075-3) 30 tablet2021-08-270000-00-00NoNoCurrent
68788-8075-66878880750660 TABLET in 1 BOTTLE (68788-8075-6) 60 tablet2021-08-270000-00-00NoNoCurrent
68788-8075-96878880750990 TABLET in 1 BOTTLE (68788-8075-9) 90 tablet2021-08-270000-00-00NoNoCurrent